Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment

This publication has 7 references indexed in Scilit:

• Characterisation of TP53 abnormalities in chronic lymphocytic leukaemia
  The Hematology Journal, 2004
• Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy
  Cell Death & Differentiation, 2003
• Determination of optimal conditions for analysis of p53 status in leukemic cells using functional analysis of separated alleles in yeast
  Pathology and Oncology Research, 2002
• Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors
  Blood, 2002
• V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia
  Blood, 2002
• p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative toTP53 mutation
  Blood, 2001
• A simple p53 functional assay for screening cell lines, blood, and tumors.
  Proceedings of the National Academy of Sciences, 1995